Daré Bioscience Announces Grant Award Of ~$385,000 Supporting Development Of Potential New Therapeutic Intervention For The Prevention Of Idiopathic Preterm Birth
Grant Funds Will Support Proof-of-Concept Target Validation Studies for Preclinical Development of a Potential New Approach for the Prevention and Treatment of Idiopathic Preterm Birth
Currently no FDA-Approved